Page 265 - Biomimetics : Biologically Inspired Technologies
P. 265

Bar-Cohen : Biomimetics: Biologically Inspired Technologies DK3163_c009 Final Proof page 251 21.9.2005 3:10am




                    Engineered Muscle Actuators                                                 251

                    these systems can employ commercially available components that are typically used in muscle
                    physiology research. For smaller muscles, or muscles at early stages of development, it is in general
                    necessary to build many of the components. The necessary instrumentation and methods have been
                    reviewed by Dennis and Kosnik (2002).
                      In addition to the quantitative performance FoM above, the following additional evaluation
                    tools can be employed to quantitatively evaluate living muscle actuator systems:

                    .    Functional resilience: Total work output capacity per unit mass of actuator over the functional
                         lifetime of the actuator (J/kg) lifetime .
                    .    Cellular function and phenotype, as determined by quantitative histology and molecular biology.
                         This will include the presence of known adult isoforms of myosin heavy chain, mitochondrial
                         density, prevalence of central nuclei in myotubes and muscle fibers, cross-sectional density of
                         contractile protein lattice, and indications of cellular necrosis or apoptosis.
                    .    Failure mode analysis and the demonstrated efficacy of countermeasures that have been engineered
                         into the living actuator system.



                                     9.6  PRACTICAL CONSIDERATIONS FOR THE
                                         USE OF LIVING MUSCLE ACTUATORS

                    When considering the use of living muscle in an engineered system, it is important to take into
                    account a number of factors that are generally not significant challenges in traditional mechatronic
                    system design.

                    9.6.1 Fuel Sources

                    Muscle ex vivo can operate on a range of fuel sources that are inexpensive and readily available.
                    Ultimately, biomechatronic designers envision the ability of a robot to eat while it travels, much
                    like a fish or a horse. It will be necessary to experimentally evaluate each fuel source for use with
                    muscle powered actuators, since each fuel source has practical limitations and advantages. These
                    include specific energy (kJ/kg), solubility, thermal lability, chemical stability, toxicity, transmem-
                    brane transport ability in the absence of systemic metabolic modulatory hormones, and second-
                    order effects such as undesired chemical reactivity. The two principal fuel groups utilized by living
                    muscle are fatty acids and sugars. Evaluation criteria should include quantitative comparisons of
                    muscle actuator efficiency and contractility.

                    9.6.2 Failure Modes

                    Based upon our experience with each class of living muscle actuators, the following modes of
                    failure have been identified. For each failure mode, the muscle actuator class(es) that are subject to
                    the failure mode is identified, the theoretical basis for the failure is addressed with supporting
                    experimental verification (if available), and corrective actions are proposed that could be imple-
                    mented in a biomechatronic system.


                    9.6.2.1 Septic Degradation of Tissue Structure

                    This mode of failure affects all types of muscle actuators and at room temperature typically results
                    in rapid functional deterioration within 24 h in the absence of countermeasures. Barrier asepsis is
                    probably not practical in the ultimate field applications of living muscle actuators. Chemical
                    countermeasures using broad-spectrum antibiotic or antimycotic formulations in the culture
                    media are effective (Dennis et al., 2000, 2001). These are commercially available for tissue and
   260   261   262   263   264   265   266   267   268   269   270